Pierre-Marie Girard, MD, PhD is currently Professor of Infectious Diseases and Tropical Medicine and Head of the Department of Infectious Diseases and Tropical Medicine, Centre Hospitalier-Universitaire St Antoine, Paris, and University Pierre et Marie Curie, Paris VI, France. He is president of Institut de Médecine et Epidémiologie Appliquée (IMEA), Fondation Internationale Léon Mba, Paris. Within the HIV research field, Dr. Girard’s main interests focused initially on clinical research in the treatment and prophylaxis of AIDS-related opportunistic infections in both low- and middle-income countries (LMIC) and high-income countries. Since the early nineties he has been involved in numerous multicentre national and international clinical trials of antiretroviral therapy (ART), both in drug evaluation and antiretroviral strategies. He has investigated the long-term tolerability of ART and access to antiretroviral drugs in LMIC. Professor Girard has a special interest in hepatitis B-HIV co-infection and in the evaluation of simplified ART regimens and induction maintenance regimens. He is the principal investigator of clinical trials of ART in France and in Sénégal, and with international groups. He currently coordinates the ANRS (French Agency for Research in AIDS and Hepatitis) site in Dakar, Senegal. He is the coordinator of infectious disease capacity building programs in Sénégal and Benin.